Skip to content
Flobotics
Book a call

XiFin Implementation: A CFO’s Perspective

A XiFin implementation changes how billing information moves through your laboratory and into financial reporting. The CFO’s job is to agree on the accounting assumptions, establish a baseline and check whether the new workflows deliver the expected result. See our overview of automation around XiFin.

Go-live is one milestone. The financial review also needs to cover expected reimbursement, unbilled work, operating costs and cash reconciliation. The seven questions below identify what to measure and what evidence to request.

Set review targets with your finance and operations teams using your payer mix, test volumes and historical results. Escalation levels should reflect your organization’s circumstances and accounting policies.

1. Net Revenue Recognition

How do expected reimbursement amounts compare with the amounts payers actually allow for settled claims?

XiFin describes expected-payment tracking and financial reporting designed to support ASC 606. That capability still needs appropriate configuration and review. Your finance team should document the reimbursement assumptions, payer-contract mapping and treatment of adjustments used in your implementation.

Compare claims from consistent service periods and payer groups. Investigate both overestimates and underestimates; an acceptable overall result can hide differences that offset one another. Reconcile the resulting reports with the general ledger and agree how exceptions will be resolved.

Illustrative dashboard. The monthly values and 3% review level below are hypothetical examples. They are not customer results, vendor benchmarks or audit limits. The light-blue series is simply 100% minus the example variance, not a measured accuracy rate.

Example review level
3.0%
Illustrative internal target
Example month
1.4%
Hypothetical variance
Example period
12
Months of sample data
Review owner
CFO
With finance and operations

Illustrative expected-versus-actual variance

Sample values; the dashed line is an example internal review level

Example variance100% minus varianceExample 3% level
Illustrative forecast variance over 12 months — hypothetical values
Example monthExample variance100% minus varianceExample review level
M12.1%97.9%3%
M22.5%97.5%3%
M32.8%97.2%3%
M42.4%97.6%3%
M51.9%98.1%3%
M61.6%98.4%3%
M71.4%98.6%3%
M81.7%98.3%3%
M91.3%98.7%3%
M101.1%98.9%3%
M111.4%98.6%3%
M121.2%98.8%3%
Below example level

A low overall variance can still hide offsetting differences. Review the underlying payer groups.

Review the cause

Investigate changes against your own reimbursement assumptions and financial review policy.

Resolve exceptions

Assign an owner to persistent differences and document their financial impact and resolution.

2. Unbilled Revenue & Cash Flow Lag

How much completed work is waiting to be billed, how long has it been waiting, and what is blocking it?

Review held claims by age and reason, including missing patient information, documentation, coding and authorization. A change in front-end edits may move work into a different queue. Check the underlying records before interpreting a larger queue as an increase in revenue or a loss of cash.

Compare accession-to-bill time and unbilled balances with your pre-implementation baseline. Agree who owns each queue, how unresolved items are escalated and how finance will assess the effect on expected cash receipts.

Evidence to request: a service-date view of unbilled work, the reasons for holds, assigned owners and a cash forecast that reflects the expected release dates.

3. Contractual Allowance

Do the fee schedules and expected reimbursement rules reflect the contracts and payment arrangements your laboratory actually uses?

Sample claims across important payer and test combinations. Compare the configured expected amount with the relevant contract terms, adjudicated allowance and recorded adjustments. Record the effective dates so a legitimate contract change is distinguishable from an incorrect mapping.

Finance and billing teams should agree how differences are classified and corrected. A single percentage threshold cannot establish whether a difference is material or identify its cause.

Evidence to request: payer-level expected-versus-allowed comparisons, the fee-schedule versions used and a record of investigated exceptions.

4. Cost to Collect & ROI Reality

What has changed in the total cost of running billing, and how much cash was collected over the same period?

HFMA’s MAP Keys define cost to collect using revenue cycle costs divided by patient service cash collected. Establish the included functions and expenses before comparing periods. A separate cost-per-claim measure uses a different denominator and should be labeled accordingly.

Include software, vendor services, retained staff, management and other relevant operating costs consistently. Track one-time implementation expenses separately so the recurring operating view remains understandable.

Hours released from manual work can provide useful capacity without immediately reducing payroll. Report that capacity separately from cash savings, and measure what the team does with it: more work completed, a smaller backlog or better follow-up.

Evidence to request: a consistently defined cost-to-collect trend, workload and staffing data, and a reconciliation to the expenses reported by finance.

How XiFin Changes Your Staffing Model

XiFin describes in-house, outsourced and combined billing arrangements. The responsibilities in a particular engagement depend on its agreed scope.

Work and oversight to define for each service model
Service modelVendor’s agreed workYour team’s workAgree in writing
Software with in-house billingPlatform and contracted supportBilling operations, exception handling and financial reviewSupport scope, access and reporting
Partially outsourcedSelected billing workflowsRetained workflows, handoffs and oversightOwnership of each queue and escalation
Outsourced billingBilling operations included in the contractVendor oversight, financial review and work outside that scopeService measures, records access and responsibility boundaries

How much does “reduced FTE” actually mean?

Staffing needs depend on claim complexity, workload and the work you keep in-house. Estimate the time your team will spend on exceptions, patient questions, reporting and vendor coordination, then recheck those estimates against actual workload after implementation.

Ask for references from organizations with comparable claim complexity and service scope. Distinguish lower paid hours from staff redeployment, avoided hiring and a temporary reduction in a backlog.

Have the appropriate finance, legal and compliance owners review oversight, records access and responsibility under the agreement. Outsourcing the work should not be treated as a reason to stop reviewing it.

5. First-Pass Resolution & Revenue Leakage

Are more claims reaching the payer correctly, and are fewer returning for avoidable corrections?

Measure clean claims, payer rejections, payment denials and denial write-offs separately. These describe different stages of the process. Use consistent definitions and compare equivalent payer groups and service periods.

Track the reasons for exceptions alongside the time spent resolving them. Eligibility, missing documentation and authorization are useful places to investigate, but the data should determine which workflow to address first.

Evidence to request: claim-edit and rejection reports, denial reasons, resolution times and actual write-offs. A change in clean-claim rate alone does not establish a fixed amount of lost revenue.

6. Patient Responsibility & Bad Debt Reserve Calibration

How are patient balances being collected, and do your estimates reflect the outcomes you actually observe?

Review patient-balance aging, payments, refunds and write-offs by a consistent cohort. If new reminders or payment options are introduced, compare results with the previous process while accounting for changes in payer mix, balance size and timing.

Faster payments do not by themselves justify changing an accounting estimate. Finance should evaluate the evidence and document any changes to collection assumptions under the organization’s accounting policies.

Evidence to request: patient-balance aging, collection outcomes over time and the assumptions used in estimates and write-offs.

7. Cash Reconciliation & Subledger Audit Integrity

Can the team trace money received through payment posting and adjustments to the general ledger?

Reconcile bank and payment-processor receipts with posted payments, refunds and unapplied cash. Investigate missing or duplicate transactions and timing differences before assigning a cause. Unapplied cash can have several causes; it is not automatically evidence of an electronic remittance failure.

During a transition, define which system owns each period and account balance. Reconcile migrated balances and open items so records from parallel systems are not counted twice. Confirm how XiFin reports and exports connect to your general ledger.

Evidence to request: bank-to-posting reconciliations, an aged unapplied-cash list, documented adjustments and sign-off on migrated balances. Set escalation criteria with the finance team using the amounts, age and circumstances involved.

The CFO’s Accountability Framework

Before go-live, record the baseline for each of these seven areas, its definition, its owner and the evidence needed for review. Agree a review schedule that reflects the implementation plan and the organization’s reporting needs.

After go-live, explain differences between the plan and actual results. Separate temporary migration effects from recurring workflow problems, and give each unresolved issue an owner and a next action.

These checks help the team assess its implementation. They do not establish universal audit thresholds, guaranteed savings or a standard payback period.

At Flobotics, we automate the manual work around healthcare revenue cycle systems. Explore our laboratory automation workflows and work around XiFin for examples.

FAQ:

Is XiFin legitimate?

XiFin is an established healthcare software and services company. Its company history dates its founding to 1997. Evaluate the particular product, service scope and contractual terms you are considering.

How many employees does XiFin have?

For a current employee count, ask XiFin directly. Directory estimates can differ by date and methodology; this article does not rely on a headcount estimate to assess its products.

Who owns XiFin?

In a November 2025 company announcement, XiFin identified Avista Healthcare Partners as its majority investor, alongside investment from Goldman Sachs External Investing Group and other institutional investors. That announcement does not provide a complete ownership breakdown.

Is XiFin a public company?

XiFin is privately held. Its February 2026 company update describes capital raised from private investors in 2025.

Written byKrzysztof Szwed

Head of Delivery at Flobotics. More from Krzysztof

Talk to us

Show us the process your team is tired of doing manually.

Let Karl, our CTO, or Bart, our Head of AI, take a look. It’s 30 minutes with someone who designs the automations, not a sales script.

Bart TeodorczukKarl Mielnicki
30-minute callKarl or BartOur CTO, or our Head of AI

Walk us through the process your team does by hand. We’ll tell you whether it’s worth automating and how we’d approach it.

Karl & Bart